AI-generated summary
The authors report a randomized, double-blind, placebo-controlled trial of photobiomodulation in teeth with lateral luxation, comparing 660 nm red light, 808 nm infrared light and sham treatment alongside splinting. Pain fell over time in all groups, with greater reduction in both laser groups than in placebo. Only the 808 nm group showed improved pulp sensitivity.
- Participants
- 41
- Who or what was studied
- Patients with lateral luxation of permanent anterior teeth (63 teeth initially; 58 teeth analyzed)
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- The abstract notes the trial's own limitations without specifying them, and three participants were lost to follow-up, leaving unequal group sizes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 660 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Laser, Placebo-controlled, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.